Login
← Go Back
Viyash Scientific
VIYASH · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in
Stock Price vs Company Growth
1d
3.6%
1w
1.4%
1m
3.6%
3m
5.9%
6m
19.8%
1y
23.7%
5y
3.0%
all
1.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 202 3.6%
188
260
Company Overview
Sales
2,126 Cr
Growth: 18.0%
Profit after Tax
76.8 Cr
Growth: -7.4%
Mid Cap
8,802 Cr
P/E: 85.1x
Industry P/E: 29.4x
Fundamentals
Sales (Cr) ₹ 2,126
Growth 18.0%
EBITDA 15.5%
P/S 4.1x
Dividend 0.0%
P/E 85.1x
Book Value ₹ 18.5
PEG Ratio 4.7x
ROE 10.4%
P/B 10.9x
Shareholding Pattern
Institutions
Infinity Holdings
5.91 %
Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii
3.35 %
Ashoka India Opportunities Fund
1.35 %
Sbi Healthcare Opportunities Fund
1.21 %
Mukul Mahavir Agrawal
1.05 %
Promoters
Ca Harbor Investments
53.02 %
Chayadeep Ventures Llp
0.27 %
Rajitha Gopalakrishnan
0.2 %
Sajitha Pillai
0.15 %
Vineetha Mohanakumar Pillai
0.12 %
Others
Increase    Decrease    No change
Company Profile Detailed
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.
Belongs to (12 Indices) view more
Investors (91)
sequent....
dilip.sh...
harish.n...
Followers (7)
jose4
joy2
ratnesh2